ReviewFuture oncology (London, England)Published
LITESPARK-012: pembrolizumab plus lenvatinib with or without belzutifan or quavonlimab for advanced renal cell carcinoma
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Review
- Venue
- Future oncology (London, England)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Phenylurea Compounds; Quinolines; Indenes; Vascular Endothelial Growth Factor A; Antineoplastic Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Clear Cell Renal Cell Carcinoma; Immune Checkpoint Inhibitor
- PubMed ID
- 37882432
- Open access
- Yes, open
- Added to directory
- Source checked